Manchanda R - Search Results

1

Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.

Sobocan M, Chandrasekaran D, Sideris M, Blyuss O, Fierheller C, Kalra A, Sia J, Miller RE, Mills-Baldock T, Crusz SM, Sun L, Evans O, Robbani S, Jenkins LA, Ahmed M, Kumar A, Quigley M, Lockley M, Faruqi A, Casey L, Brockbank E, Phadnis S, Trevisan G, Singh N, Legood R, Manchanda R. Sobocan M, et al. Among authors: manchanda r. BJOG. 2024 May;131(6):848-857. doi: 10.1111/1471-0528.17675. Epub 2023 Sep 26. BJOG. 2024. PMID: 37752678

2

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.

Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U. Manchanda R, et al. BJOG. 2011 Jun;118(7):814-24. doi: 10.1111/j.1471-0528.2011.02920.x. Epub 2011 Mar 10. BJOG. 2011. PMID: 21392246

3

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.

Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A, Benjamin E, Brunell C, Saridogan E, Gessler S, Oram D, Side L, Rosenthal AN, Jacobs I, Menon U. Manchanda R, et al. BJOG. 2012 Apr;119(5):527-36. doi: 10.1111/j.1471-0528.2011.03257.x. Epub 2012 Jan 20. BJOG. 2012. PMID: 22260402

4

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.

Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, Beller U, Menon U, Jacobs I. Manchanda R, et al. J Natl Cancer Inst. 2014 Nov 30;107(1):380. doi: 10.1093/jnci/dju380. Print 2015 Jan. J Natl Cancer Inst. 2014. PMID: 25435542 Free PMC article.

5

Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK.

Chandrasekaran D, Menon U, Evans G, Crawford R, Saridogan E, Jacobs C, Tischkowitz M, Brockbank E, Kalsi J, Jurkovic D, Manchanda R. Chandrasekaran D, et al. Among authors: manchanda r. Fam Cancer. 2015 Dec;14(4):521-30. doi: 10.1007/s10689-015-9823-y. Fam Cancer. 2015. PMID: 26178205

6

Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women.

Manchanda R, Legood R, Pearce L, Menon U. Manchanda R, et al. Gynecol Oncol. 2015 Dec;139(3):487-94. doi: 10.1016/j.ygyno.2015.10.001. Epub 2015 Oct 5. Gynecol Oncol. 2015. PMID: 26436478

7

Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated Into Routine Care or Offered in the Context of a Clinical Trial?

Manchanda R, Chandrasekaran D, Saridogan E, Burnell M, Crawford R, Brockbank E, Kalsi J, Jurkovic D, Menon U. Manchanda R, et al. Int J Gynecol Cancer. 2016 Jan;26(1):31-3. doi: 10.1097/IGC.0000000000000567. Int J Gynecol Cancer. 2016. PMID: 26658362 No abstract available.

8

Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: There is lack of clarity on a number of key issues.

Manchanda R, Menon U. Manchanda R, et al. BJOG. 2016 Feb;123(3):463. doi: 10.1111/1471-0528.13741. BJOG. 2016. PMID: 26810679 No abstract available.

9

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.

Manchanda R, Burnell M, Loggenberg K, Desai R, Wardle J, Sanderson SC, Gessler S, Side L, Balogun N, Kumar A, Dorkins H, Wallis Y, Chapman C, Tomlinson I, Taylor R, Jacobs C, Legood R, Raikou M, McGuire A, Beller U, Menon U, Jacobs I. Manchanda R, et al. J Med Genet. 2016 Jul;53(7):472-80. doi: 10.1136/jmedgenet-2015-103740. Epub 2016 Mar 18. J Med Genet. 2016. PMID: 26993268 Clinical Trial.

10

Benchmarking of surgical complications in gynaecological oncology: prospective multicentre study.

Burnell M, Iyer R, Gentry-Maharaj A, Nordin A, Liston R, Manchanda R, Das N, Gornall R, Beardmore-Gray A, Hillaby K, Leeson S, Linder A, Lopes A, Meechan D, Mould T, Nevin J, Olaitan A, Rufford B, Shanbhag S, Thackeray A, Wood N, Reynolds K, Ryan A, Menon U. Burnell M, et al. Among authors: manchanda r. BJOG. 2016 Dec;123(13):2171-2180. doi: 10.1111/1471-0528.13994. Epub 2016 Mar 22. BJOG. 2016. PMID: 27006076 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page